ID: ALA3808922

Max Phase: Preclinical

Molecular Formula: C19H24O4

Molecular Weight: 316.40

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1cc(CC[C@H](C)Cc2ccc(O)c(OC)c2)ccc1O

Standard InChI:  InChI=1S/C19H24O4/c1-13(10-15-7-9-17(21)19(12-15)23-3)4-5-14-6-8-16(20)18(11-14)22-2/h6-9,11-13,20-21H,4-5,10H2,1-3H3/t13-/m0/s1

Standard InChI Key:  HLIXECJKMYVPFX-ZDUSSCGKSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 316.40

Molecular Weight (Monoisotopic): 316.1675

AlogP: 3.93

#Rotatable Bonds: 7

Polar Surface Area: 58.92

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 9.98

CX Basic pKa:

CX LogP: 4.76

CX LogD: 4.76

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.81

Np Likeness Score: 0.67

References

1. Yamauchi S, Tanimura R, Nishiwaki H, Nishi K, Sugahara T, Maruyama M, Ano Y, Akiyama K, Kishida T..  (2016)  Enantioselective syntheses of both enantiomers of 9'-dehydroxyimperanene and 7,8-dihydro-9'-dehydroxyimperanene and the comparison of biological activity between 9-norlignans and dihydroguaiaretic acids.,  26  (13): [PMID:27210431] [10.1016/j.bmcl.2016.05.020]

Source

Source(1):

• Scientific Literature